PH Stock Analysis: Parker-Hannifin | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 116.630m USD | 12M Return: 32.4% | US7010941042 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 570M
EPS Trend: 98.3%
Qual. Beats: 5
Rev. Trend: 79.1%
Qual. Beats: 5
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Parker-Hannifin Corporation (NYSE: PH) is a global manufacturer of motion and control technologies serving six end markets: aerospace and defense, in-plant and industrial equipment, transportation, off-highway, energy, and HVAC and refrigeration. The company operates worldwide across North America, Europe, Asia Pacific, and Latin America, and is organized into two reporting segments: Diversified Industrial and Aerospace Systems. Its product portfolio spans motion-control systems, sealing solutions, filtration, fluid conveyance, pumps, valves, actuators, electromechanical and hydraulic components, thermal management, and sensors, sold primarily to original equipment manufacturers (OEMs), distributors, and direct-sales channels. The company was founded in 1917 and is headquartered in Cleveland, Ohio.
As a member of the GICS Industrials sector (Industrial Machinery & Supplies & Components sub-industry), Parker operates a classic B2B industrial supplier model, embedding its components into customers end products rather than selling finished goods to consumers. The two-segment structure is notable because the Aerospace Systems segment, which supplies avionics, flight controls, braking, fuel systems, and thermal management for both commercial and defense airframe and engine programs, typically carries higher margins and longer product lifecycles than the more manufacturing-cycle-sensitive Diversified Industrial segment.
- Boeing and Airbus production rate hikes boost Aerospace Systems segment revenue
- Meggitt acquisition accelerates aerospace aftermarket and service revenue growth
- Diversified Industrial margins expand on Win Strategy pricing and cost initiatives
| Net Income: 3.65b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 1.32 > 1.0 |
| NWC/Revenue: 7.44% < 20% (prev 5.70%; Δ 1.74% < -1%) |
| CFO/TA 0.14 > 3% & CFO 4.36b > Net Income 3.65b |
| Net Debt (8.23b) to EBITDA (5.81b): 1.42 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.8m) vs 12m ago -0.93% < -2% |
| Gross Margin: 37.69% > 18% (prev 36.93%; Δ 0.75% > 0.5%) |
| Asset Turnover: 71.22% > 50% (prev 67.30%; Δ 3.92% > 0%) |
| Interest Coverage Ratio: 12.38 > 6 (EBIT TTM 4.96b / Interest Expense TTM 401.0m) |
| A: 0.05 (Total Current Assets 7.70b - Total Current Liabilities 6.10b) / Total Assets 30.9b |
| B: 0.79 (Retained Earnings 24.5b / Total Assets 30.9b) |
| C: 0.16 (EBIT TTM 4.96b / Avg Total Assets 30.2b) |
| D: 1.00 (Book Value of Equity 15.4b / Total Liabilities 15.5b) |
| Altman-Z'' = 5.08 = AAA |
| DSRI: 1.00 (Receivables 3.67b/3.38b, Revenue 21.5b/19.9b) |
| GMI: 0.98 (GM 36.93% / 37.69%) |
| AQI: 0.97 (AQ_t 0.65 / AQ_t-1 0.66) |
| SGI: 1.08 (Revenue 21.5b / 19.9b) |
| TATA: -0.02 (NI 3.65b - CFO 4.36b) / TA 30.9b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of September 27, 2026, the stock is trading at USD 978.33 with a total of 591,887 shares traded. Over the past week, the price has changed by +3.69%, over one month by -3.54%, over three months by -0.97% and over the past year by +32.40%.
Current recommended Stop Loss: 922.40 (which is 5.7% or 2.5 ATR below the current price).
Parker-Hannifin has received a consensus analysts rating of 4.35. Therefore, it is recommended to buy PH.
- StrongBuy: 16
- Buy: 4
- Hold: 5
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 1161 | 18.7% |
P/E Trailing = 32.2626
P/E Forward = 26.178
P/S = 5.4249
P/B = 7.5179
P/EG = 3.0768
Revenue TTM = 21.5b USD
EBIT TTM = 4.96b USD
EBITDA TTM = 5.81b USD
Long Term Debt = 6.77b USD (from longTermDebt, last quarter)
Short Term Debt = 1.80b USD (from shortTermDebt, last quarter)
Debt = 8.73b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.23b USD (calculated: Debt 8.73b - CCE 501.0m)
Enterprise Value = 125b USD (117b + Debt 8.73b - CCE 501.0m)
Interest Coverage Ratio = 12.38 (Ebit TTM 4.96b / Interest Expense TTM 401.0m)
EV/FCF = 31.98x (Enterprise Value 125b / FCF TTM 3.90b)
FCF Yield = 3.13% (FCF TTM 3.90b / Enterprise Value 125b)
FCF Margin = 18.16% (FCF TTM 3.90b / Revenue TTM 21.5b)
Net Margin = 16.97% (Net Income TTM 3.65b / Revenue TTM 21.5b)
Gross Margin = 37.69% ((Revenue TTM 21.5b - Cost of Revenue TTM 13.4b) / Revenue TTM)
Gross Margin QoQ = 39.04% (prev 36.77%)
Tobins Q-Ratio = 4.04 (Enterprise Value 125b / Total Assets 30.9b)
Interest Expense / Debt = 4.59% (Interest Expense 401.0m / Debt 8.73b)
Taxrate = 20.03% (914.0m / 4.56b)
NOPAT = 3.97b (EBIT 4.96b * (1 - 20.03%))
Current Ratio = 1.26 (Total Current Assets 7.70b / Total Current Liabilities 6.10b)
Debt / Equity = 0.57 (Debt 8.73b / totalStockholderEquity, last quarter 15.4b)
Debt / EBITDA = 1.42 (Net Debt 8.23b / EBITDA 5.81b)
Debt / FCF = 2.11 (Net Debt 8.23b / FCF TTM 3.90b)
Total Stockholder Equity = 14.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.09% (Net Income 3.65b / Total Assets 30.9b)
RoE = 25.11% (Net Income TTM 3.65b / Total Stockholder Equity 14.5b)
RoCE = 23.31% (EBIT 4.96b / Capital Employed (Equity 14.5b + L.T.Debt 6.77b))
RoIC = 15.22% (NOPAT 3.97b / Invested Capital 26.1b)
WACC = 9.78% (E(117b)/V(125b) * Re(10.24%) + D(8.73b)/V(125b) * Rd(4.59%) * (1-Tc(0.20)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.07 | Cagr: -0.96%
[DCF] Terminal Value 73.48% ; FCFF base≈3.68b ; Y1≈4.22b ; Y5≈6.21b
[DCF] Fair Price = 526.3 (EV 74.6b - Net Debt 8.23b = Equity 66.3b / Shares 126.0m; r=9.78% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.33 | EPS CAGR: 11.93% | SUE: 4.0 | # QB: 5
Revenue Correlation: 79.15 | Revenue CAGR: 2.41% | SUE: 2.35 | # QB: 5
EPS current Quarter (2026-09-30): EPS=8.13 | Chg30d=+0.11% | Revisions=+50% | Analysts=8
EPS next Quarter (2026-12-31): EPS=8.45 | Chg30d=+0.40% | Revisions=+50% | Analysts=8
EPS current Year (2027-06-30): EPS=35.32 | Chg30d=+0.09% | Revisions=+67% | GrowthEPS=+9.3% | GrowthRev=+12.7%
EPS next Year (2028-06-30): EPS=39.16 | Chg30d=+4.40% | Revisions=+57% | GrowthEPS=+10.9% | GrowthRev=+8.2%
[Analyst] Revisions Ratio: +84% (up=16, down=0)